life. This time, he was assigned as Professor of Biomedical Sciences at University of Arizona, Phoenix. Dr Peyman's achievements are outstanding. He has authored 879 scientific papers, 10 books, and 4 book chapters during his accomplished career that spans through 40 years and still continues today. He is a member of the editorial board of 9 distinguished ophthalmology journals. He has received the most prestigious of awards and achieved the highest of accolades including the Lifetime Achievement Award of the American Academy of Ophthalmology and inclusion in the American Society of Cataract and Refractive Surgery (ASCRS) Hall of Fame.
Dr Peyman conducted pioneering studies in intraocular drug delivery, and refractive and vitreoretinal surgery. He established the techniques of eye-wall resection and endoresection for intraocular tumors, and was the first to perform a retinochoroidal biopsy and transplant retinal pigment epithelial cells for age-related macular degeneration. He is also a pioneer in photodynamic therapy. Dr Peyman's innovative investigations have resulted in 120 US patents, the most for any ophthalmologist. He described the first pressure-controlled valve (the Krupin valve) for glaucoma surgery, and with Dr Koziol, he developed the first telescopic IOL for patients with macular disease. He was also among the first to implant an artificial silicone retina in patients with retinitis pigmentosa.
Perhaps the most recognized work was a patent filed in 1985 for the use of excimer lasers for correction of refractive errors by stromal ablation under a corneal flap, the currently well-known procedure called LASIK. 
